BanColombia S.A. (NYSE:CIB) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday.

According to Zacks, “BanColombia is Colombia’s largest bank in terms of assets and also has the largest market participation in deposit products and loans. “

Several other research firms have also recently commented on CIB. HSBC Holdings plc cut shares of BanColombia from a “buy” rating to a “hold” rating in a research note on Tuesday, August 15th. J P Morgan Chase & Co reaffirmed a “neutral” rating and issued a $41.00 price objective (down previously from $42.00) on shares of BanColombia in a research note on Monday, June 5th. BidaskClub raised shares of BanColombia from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 1st. Credit Suisse Group set a $45.00 price objective on shares of BanColombia and gave the stock a “hold” rating in a research note on Wednesday, May 24th. Finally, Standpoint Research cut shares of BanColombia from a “buy” rating to a “hold” rating in a research note on Monday, May 22nd. One analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $45.00.

Shares of BanColombia (NYSE CIB) traded down 1.96% during midday trading on Wednesday, reaching $44.09. The company’s stock had a trading volume of 213,099 shares. BanColombia has a 52 week low of $31.98 and a 52 week high of $47.19. The company has a 50 day moving average of $44.01 and a 200-day moving average of $41.74. The stock has a market capitalization of $10.60 billion, a price-to-earnings ratio of 10.72 and a beta of 0.32.

TRADEMARK VIOLATION NOTICE: This article was first published by Watch List News and is owned by of Watch List News. If you are accessing this article on another domain, it was illegally stolen and reposted in violation of international copyright law. The original version of this article can be read at https://www.watchlistnews.com/bancolombia-s-a-cib-downgraded-to-hold-at-zacks-investment-research/1532557.html.

Several hedge funds and other institutional investors have recently made changes to their positions in CIB. Bank of Montreal Can boosted its stake in BanColombia by 2,896.6% in the first quarter. Bank of Montreal Can now owns 26,130 shares of the bank’s stock valued at $1,041,000 after buying an additional 25,258 shares in the last quarter. DnB Asset Management AS bought a new stake in BanColombia during the first quarter valued at approximately $439,000. Huntington National Bank boosted its stake in BanColombia by 12.7% in the first quarter. Huntington National Bank now owns 3,235 shares of the bank’s stock valued at $129,000 after buying an additional 365 shares in the last quarter. Nationwide Fund Advisors boosted its stake in BanColombia by 288.9% in the first quarter. Nationwide Fund Advisors now owns 175,000 shares of the bank’s stock valued at $6,977,000 after buying an additional 130,000 shares in the last quarter. Finally, Profund Advisors LLC boosted its stake in BanColombia by 39.9% in the first quarter. Profund Advisors LLC now owns 17,028 shares of the bank’s stock valued at $679,000 after buying an additional 4,853 shares in the last quarter. Institutional investors own 14.96% of the company’s stock.

BanColombia Company Profile

Bancolombia SA (Bancolombia) is a financial institution engaged in providing a range of financial products and services to a diversified individual, corporate, and government customer base throughout Colombia, Latin America and the Caribbean region. The Bank operates through 10 segments: Banking Colombia, Banking Panama, Banking El Salvador, Leasing, Trust, Investment Banking, Brokerage, Off Shore and All other.

Analyst Recommendations for BanColombia (NYSE:CIB)

Receive News & Ratings for BanColombia S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BanColombia S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.